Imaging in Pre-Clinical & Clinical Drug Development
March 15-16, 2007, in Cambridge, MA

http://www.gtcbio.com/conference/conferenceDetails.aspx?id=79

Biomedical imaging is poised to play an increasingly powerful role in enhancing the efficiency of the drug discovery and development process. As an attendee at this year's Imaging in Pre-clinical & Clinical Drug Development conference you will hear from leading experts on a wide range of topics such as:

* Multimodality Imaging of Disease Models
* Commercialization of Research Tools
* Preclinical Imaging (MR, Optical Imaging, Nuclear and Other Modalities)
* Imaging Applications (Vascular, Oncology, CNS Inflammation)

Register by Feb 15 to receive 10% discount

ABSTRACT SUBMISSION DEADLINE: February 15, 2007
Oral presenters will be selected!
Submit your abstract before February 15th to be considered: http://www.gtcbio.com/conference/user_abstract.aspx

Distinguished Faculty:

Gerard Fox, Ph.D., Abbott Laboratories
Tad C. George, Amnis Corporation
Suzanne V. Smith, Ph.D., Australian Nuclear Science & Technology Org.
Padmaja Yalamanchili, Ph.D., Bristol Myers Squibb Medical Imaging
Andreas H. Hielscher, Ph.D., Columbia University
Joy Hirsch, Columbia University
Cristian Badea, Ph.D., David Geffen School of Medicine, UCLA
Richard Smith, Edwards Angell Palmer & Dodge
Michael C. Montalto, Ph.D., GE Global Research
Andrew Lockhart, Ph.D., GlaxoSmithKline (UK)
Richard Margolin, M.D., i3Research, David Geffen School of Medicine, UCLA
Bruce G. Jenkins, Ph.D., Mass. General Hospital, Harvard Medical School
David Borsook, McLean Hospital
Michelle Bradbury, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center
Shil (Shailendra) Patel, Ph.D., Merck Research Laboratories
Georgina Meneses-lorente, Merck Sharp & Dohme
Yumin Zhang, Millenium Pharmaceuticals
Thomas Krucker, Ph.D., Novartis
Paul Lang, Serono Pharmaceuticals
Jonathan H. Gillard, BSc, M.D., FRCR, University of Cambridge
Mac Johnson, Vertex Pharmaceutical
Peter Lasota, Xenogen/Caliper Lifesciences